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September 2009706 Letters to the Editorreport if the total aortic cross-clamping time is significantly associ-
ated with spinal cord injury in a multivariate regression analysis
model, independently of the combination of other protective
strategies.
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Reply
The publication of Biglioli et al1 comprises patients with
descending thoracic aneurysms and the very short clamping times
indicate the limited extent of the aneurysms in a substantial num-
ber of patients. Aortic arch arteries at the proximal site or visceral
arteries at the distal site were not involved in the aneurysm. The
majority of these aneurysms would currently be treated by means
of endovascular techniques.
The pathology of patients in our publication is entirely differ-
ent and, therefore, not comparable. The aortic pathology included
the aortic arch, descending aorta, and/or the abdominal aorta,
affecting supra-aortic, visceral, and renal arteries. Total aortic
clamp times in these extensive repairs exceed many hours and
would not be tolerated without extracorporeal circulation. There-
fore, we did not consider aortic clamp times as an important
parameter.
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Regarding “What a vascular surgeon should know
and do about atherosclerotic risk factors”
Liapis et al provide an excellent guide for the management of
the various conventional, conditional and emerging vascular risk
factors.1
A risk factor that may deserve more attention is hypertriglyc-
eridemia. Currently, hypertriglyceridemia is considered as a condi-tional risk factor.1 According to the AHA/ACC Guidelines,2 as
well as the recommendations of the authors,1 lowering triglyceride
levels 1.7 mmol/l (150 mg/dl) is a secondary target, whereas
lowering low-density lipoprotein cholesterol (LDL-C) levels2.6
mmol/l (100 mg/dl) is a primary target. However, if triglycer-
ides are 500 mg/dl, the treatment of LDL-C to goal becomes a
secondary target;2 triglyceride-lowering therapy should be initiated
immediately to prevent the development of acute pancreatitis.2
The importance of aiming at normal triglyceride levels to
prevent cardiovascular disease could already be extrapolated from a
study published more than three decades ago.3 This study evalu-
ated the presence of coronary artery disease and peripheral arterial
disease (PAD) in 280 patients with different types of primary
hyperlipoproteinemia. It was demonstrated that the prevalence of
PAD was much higher in patients with hypertriglyceridemia (21%
in Type IIb; 20% in Type V) than in subjects with hypercholester-
olemia alone (9% in Type IIa).3
In a nested case-control study, plasma samples were collected
at baseline from a prospective cohort of 14,916 initially healthy
individuals aged 40 to 84 years.4 During an average follow-up
period of nine years, 140 subjects developed PAD. Although the
total cholesterol/high-density lipoprotein cholesterol ratio was the
strongest predictor for the development of PAD (relative risk
[RR], 3.4; 95% confidence interval [CI], 1.7-7.0; P .001), high
triglyceride levels at baseline were an independent risk factor and
almost equally strong predictor (RR, 2.9; 95% CI, 1.4-5.8; P 
.001).4
Similarly, the Atherosclerosis Risk in Communities (ARIC)
Study assessed the relation of traditional and non-traditional risk
factors with the risk of PAD in 1,651 participants with diabetes,
but not PAD, at baseline.5 After a mean follow-up of 10.3 years,
the risk of developing PAD was increased 1.75-fold (95% CI:
1.18-2.60) for the highest versus the lowest quartile of triglycer-
ides.5 Surprisingly, no evidence was found of any association
between the development of PAD with other blood lipids or
hypertension.5
Hypercholesterolemia is indeed the strongest predictor of
cardiovascular disease and should thus comprise a primary thera-
peutic target.1,2,4 Nevertheless, hypertriglyceridemia should not
be viewed as a secondary therapeutic goal under all circumstances
(eg, when triglycerides500 mg/dl).2 Hypertriglyceridemia is an
important vascular risk factor, the management of which should
not be neglected. Given the association between hypertriglyceri-
demia, atherosclerosis, and cardiovascular risk,6 future guidelines
may need to consider hypertriglyceridemia as a conventional and
not a conditional risk factor.1
Kosmas I. Paraskevas, MD, FASA
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